Rheumatology Education and CME

Select a Specialty

HEA070
CMEABIM MOC

Ace the Case: A 55-Year-Old Man With RA and Increasing Joint Symptoms After Methotrexate Use

There is no commercial support for this activity.

Expiration Date: 7/14/2019
Credit Type(s): CME / ABIM MOC | Credit: 0.25

This educational activity will discuss the management of a 55-year-old man with rheumatoid arthritis and increasing joint symptoms after methotrexate….

go to activity»
ATC
CMEABIM MOC

Ace the Case: A 60-Year-Old-Man with Worsening Chronic Right Knee Pain

There is no commercial support for this activity.

Expiration Date: 6/14/2019
Credit Type(s): CME / ABIM MOC | Credit: 0.25

This educational activity will utilize a case study to discuss the diagnosis and treatment of a 60-year-old male with worsening chronic right knee pain….

go to activity»
ATC
CMEABIM MOC

Ace the Case: A 64-Year-Old Man with Painful Knee Osteoarthritis Who Does Not Want a Total Knee Arthroplasty

There is no commercial support for this activity.

Expiration Date: 5/14/2019
Credit Type(s): CME / ABIM MOC | Credit: 0.25

This educational activity will utilize a case study to discuss the diagnosis and treatment options for a 64-year-old male with knee pain….

go to activity»
Understanding Biosimilars

The goal of biosimilar development is to spur competition in the biologics market and thereby reduce costs to the health care system and expand patient access to…

go to activity»
Understanding Biosimilars

An abbreviated licensure pathway was developed for biologics that are “biosimilar” to FDA-approved reference products, reducing costs and expanding patient access to…

go to activity»
Understanding Biosimilars

To clarify some of the details surrounding the abbreviated licensure pathway for biosimilars, Healio spoke with Leah Christl, PhD, associate director for therapeutic…

go to activity»
Rheumatoid Arthritis Central

Read the latest on emerging therapies, review important clinical trials and explore future treatment and management….

go to activity»
Biosimilars in Rheumatology: Helpful Information When Considering a Biosimilar

Biosimilars in Rheumatology: Helpful Information When Considering a Biosimilar

This activity is sponsored by Janssen Biotech, Inc.

May 22, 2018

The development of biologic products has revolutionized the field of rheumatology; biologic products are now commonplace in rheumatology practices….

go to activity»
Understanding Biosimilars

As more biosimilars are approved by the FDA, and with more in the development pipeline, the issue of interchangeability is causing concern among physicians about the…

go to activity»
Understanding Biosimilars

Biosimilars are here, and physicians should arm themselves with knowledge to better prepare themselves and their patients for the future….

go to activity»
Understanding Biosimilars

The proliferation and success of biotherapeutics for a variety of autoimmune, autoinflammatory and related conditions have come at a massive societal cost in terms of…

go to activity»
Understanding Biosimilars

Four things you should know about the next wave of treatment for chronic diseases—biosimilars….

go to activity»